Compare Danimer Scientific, Inc. with Similar Stocks
Stock DNA
Specialty Chemicals
USD 0 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
1.75
-58.40%
0.00
Revenue and Profits:
Net Sales:
9 Million
(Quarterly Results - Sep 2024)
Net Profit:
-22 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-98.2%
0%
-98.2%
6 Months
-99.57%
0%
-99.57%
1 Year
-99.92%
0%
-99.92%
2 Years
-99.98%
0%
-99.98%
3 Years
-99.99%
0%
-99.99%
4 Years
-100.0%
0%
-100.0%
5 Years
-99.99%
0%
-99.99%
Danimer Scientific, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
148.98%
EBIT Growth (5y)
-404.14%
EBIT to Interest (avg)
-26.64
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.75
Sales to Capital Employed (avg)
0.07
Tax Ratio
0.01%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
41.25%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.00
EV to EBIT
-4.26
EV to EBITDA
-6.48
EV to Capital Employed
0.64
EV to Sales
9.89
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-14.95%
ROE (Latest)
-58.40%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Bearish
Bearish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot : Sep 2024
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 25 Schemes (13.75%)
Foreign Institutions
Held by 46 Foreign Institutions (5.77%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Sep'24 - QoQ
Sep'24
Jun'24
Change(%)
Net Sales
8.60
7.60
13.16%
Operating Profit (PBDIT) excl Other Income
-11.40
-11.30
-0.88%
Interest
9.60
9.10
5.49%
Exceptional Items
6.60
5.70
15.79%
Consolidate Net Profit
-21.80
-22.70
3.96%
Operating Profit Margin (Excl OI)
-2,173.30%
-2,459.90%
28.66%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2024 is 13.16% vs -25.49% in Jun 2024
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2024 is 3.96% vs 16.85% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
46.70
53.20
-12.22%
Operating Profit (PBDIT) excl Other Income
-96.10
-103.90
7.51%
Interest
29.60
1.70
1,641.18%
Exceptional Items
-0.10
-55.60
99.82%
Consolidate Net Profit
-155.50
-179.80
13.52%
Operating Profit Margin (Excl OI)
-2,681.50%
-2,328.90%
-35.26%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is -12.22% vs -9.37% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 13.52% vs -199.17% in Dec 2022
About Danimer Scientific, Inc. 
Danimer Scientific, Inc.
Specialty Chemicals
No Details Available.
Company Coordinates 
No Company Details Available






